Fig. 1From: Efficacy of different nucleoside analog rescue therapies for entecavir-resistant chronic hepatitis B patientsTrends of nucleos(t)ide analogue resistance mutations. Occurrence rate of ETV resistance varies from 2011–2017, A Number of patients with LMV resistance and ETV resistance; B Proportion of LMV resistance and ETV resistance among all patients with nucleos(t)ide analogue resistanceBack to article page